Management of coexisting conditions in the context of COVID-19

1. American College of Obstetricians and Gynaecologists. Novel coronavirus 2019 (COVID-19). Dec 2020 [internet publication].Full text external link opens in a new window

2. Poon LC, Yang H, Kapur A, et al. Global interim guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium from FIGO and allied partners: information for healthcare professionals. Int J Gynaecol Obstet. 2020 Jun;149(3):273-86.Full text external link opens in a new window Abstract external link opens in a new window

3. Allotey J, Stallings E, Bonet M, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2021 Mar 12:70(10);355-61.Full text external link opens in a new window Abstract external link opens in a new window

4. Delahoy MJ, Whitaker M, O’Halloran A, et al. Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19 — COVID-NET, 13 States, March 1–August 22, 2020. MMWR Morb Mortal Wkly Rep. 2020 Sep 25;69(38):1347-54.Full text external link opens in a new window Abstract external link opens in a new window

5. Knight M, Bunch K, Cairns A, et al on behalf of MBRRACE-UK. Saving Lives, Improving Mothers’ Care Rapid Report: Learning from SARS-CoV-2-related and associated maternal deaths in the UK March – May 2020. National Perinatal Epidemiology Unit, University of Oxford. Aug 2020 [internet publication].Full text external link opens in a new window

6. Knight M, Bunch K, Vousden N, et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. BMJ. 2020 Jun 8;369:m2107.Full text external link opens in a new window Abstract external link opens in a new window

7. NHS England. NHS boosts support for pregnant black and ethnic minority women. Jun 2020 [internet publication].Full text external link opens in a new window

8. Ellington S, Strid P, Tong VT, et al. Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-June 7, 2020. MMWR Morb Mortal Wkly Rep 2020 Jun 26;69(25):769-75.Full text external link opens in a new window

9. Ahlberg M, Neovius M, Saltvedt S, et al. Association of SARS-CoV-2 Test Status and Pregnancy Outcomes. JAMA. 2020 Sep 23;324(17):1782-5.Full text external link opens in a new window Abstract external link opens in a new window

10. Woodworth KR, Olsen EO, Neelam V, et al. Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy - SET-NET, 16 Jurisdictions, March 29-October 14, 2020. MMWR Morb Mortal Wkly Rep. 2020 Nov 6;69(44):1635-40.Full text external link opens in a new window Abstract external link opens in a new window

11. Jering KS, Claggett BL, Cunningham JW, et al. Clinical Characteristics and Outcomes of Hospitalized Women Giving Birth With and Without COVID-19. JAMA Intern Med. 2021 Jan 15 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

12. Panagiotakopoulos L, Myers TR, Gee J, et al. SARS-CoV-2 Infection Among Hospitalized Pregnant Women: Reasons for Admission and Pregnancy Characteristics — Eight U.S. Health Care Centers, March 1–May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020 Sep 23;69(38):1355-9.Full text external link opens in a new window Abstract external link opens in a new window

13. Jering KS, Claggett BL, Cunningham JW, et al. Clinical Characteristics and Outcomes of Hospitalized Women Giving Birth With and Without COVID-19. JAMA Intern Med. 2021 Jan 15 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

14. Khoury R, Bernstein PS, Debolt C, et al. Characteristics and Outcomes of 241 Births to Women With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection at Five New York City Medical Centers. Obstet Gynecol. 2020 Aug;136(2):273-82.Full text external link opens in a new window Abstract external link opens in a new window

15. Metz TD, Clifton RG, Hughes BL, et al. Disease severity and perinatal outcomes of pregnant patients with coronavirus disease 2019 (COVID-19). Obstet Gynecol. 2021 Apr 1;137(4):571-80.Full text external link opens in a new window Abstract external link opens in a new window

16. Flaherman VJ, Afshar Y, Boscardin J, et al. Infant Outcomes Following Maternal Infection with SARS-CoV-2: First Report from the PRIORITY Study Clin Infect Dis. Sep 2020 [internet publication].Full text external link opens in a new window Abstract external link opens in a new window

17. Norman M, Navér L, Söderling J, et al. Association of maternal SARS-CoV-2 infection in pregnancy with neonatal outcomes. JAMA. 29 Apr 2021 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

18. Royal College of Midwives and Royal College of Obstetricians and Gynaecologists. Coronavirus (COVID-19) infection and pregnancy. Feb 2021 [internet publication].Full text external link opens in a new window

19. American College of Obstetricians and Gynecologists (ACOG). Vaccinating Pregnant and Lactating Patients Against COVID-19. Apr 2021 [internet publication].Full text external link opens in a new window

20. Centers for Disease Control and Prevention. Information about COVID-19 vaccines for people who are pregnant or breastfeeding. Apr 2021 [internet publication].Full text external link opens in a new window

21. Public Health England. COVID-19: the green book, chapter 14a: Coronavirus (COVID-19) vaccination information for public health professionals. May 2021 [internet publication].Full text external link opens in a new window

22. Shimabukuro TT, Kim SY, Myers TR, et al. Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. N Engl J Med. 21 Apr 2021 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

23. Gill L, Jones C. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in neonatal cord blood after vaccination in pregnancy. Obstet Gynecol. 2021 May 1;137(5):894-6.Full text external link opens in a new window Abstract external link opens in a new window

24. Perl S, Uzan-Yulzari A, Klainer H, et al. SARS-CoV-2–Specific antibodies in breast milk after COVID-19 vaccination of breastfeeding women. JAMA. 12 April 2021 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

25. Gray KJ, Bordt EA, Atyeo C, et al. COVID-19 vaccine response in pregnant and lactating women: a cohort study. Am J Obstet Gynecol. 24 Mar 2021 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

26. Berthelot N, Lemieux R, Garon‐Bissonnette J, et al. Uptrend in distress and psychiatric symptomatology in pregnant women during the coronavirus disease 2019 pandemic. 2020 Jul;99(7):848-55.Full text external link opens in a new window Abstract external link opens in a new window

27. Papworth R, Harris A, Durcan G, et al. Maternal mental health during a pandemic. A rapid evidence review of Covid-19's impact. Mar 2021 [internet publication].Full text external link opens in a new window

28. Royal College of Midwives and Royal College of Obstetricians and Gynaecologists. Guidance for antenatal and postnatal services in the evolving coronavirus (COVID-19) pandemic. Oct 2020 [internet publication].Full text external link opens in a new window

29. Scottish Intercollegiate Guideline Network. COVID-19 position statement: maternal critical care provision. Nov 2020 [internet publication].Full text external link opens in a new window

30. Centers for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19). Considerations for inpatient obstetric healthcare settings. Dec 2020 [internet publication].Full text external link opens in a new window

31. American College of Obstetricians and Gynecologists. COVID-19 FAQs for obstetrician-gynecologists, obstetrics. Mar 2021 [internet publication].Full text external link opens in a new window

32. World Health Organization. Clinical management of COVID-19: living guidance. Jan 2021 [internet publication].Full text external link opens in a new window

33. Royal College of Midwives and Royal College of Obstetricians and Gynaeologists. Guidance for provision of midwife-led settings and home birth in the evolving coronavirus (COVID-19) pandemic. Oct 2020 [internet publication].Full text external link opens in a new window

34. American Academy of Pediatrics. FAQs: management of infants born to mothers with suspected or confirmed COVID-19. Feb 2021 [internet publication].Full text external link opens in a new window

35. Salvatore CM, Han JY, Acker KP, et al. Neonatal management and outcomes during the COVID-19 pandemic: an observation cohort study. Lancet Child Adolesc Health. 2020 Oct;4(10):721-7.Full text external link opens in a new window Abstract external link opens in a new window

36. Dumitriu D, Emeruwa UN, Hanft E, et al. Outcomes of Neonates Born to Mothers With Severe Acute Respiratory Syndrome Coronavirus 2 Infection at a Large Medical Center in New York City. JAMA Pediatr. Oct 2020 [internet publication].Full text external link opens in a new window Abstract external link opens in a new window

37. Ronchi A, Pietrasanta C, Zavattoni M, et al. Evaluation of Rooming-in Practice for Neonates Born to Mothers With Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Italy. JAMA Pediatr. 2021 Mar 1;175(3):260-6.Full text external link opens in a new window Abstract external link opens in a new window

38. Flannery DD, Gouma S, Dhudasia MB, et al. Assessment of Maternal and Neonatal Cord Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios. JAMA Pediatr. 29 Jan 2021 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

39. Royal College of Paediatrics and Child Health. BAPM - COVID-19: Frequently asked questions within neonatal settings. Mar 2021 [internet publication].Full text external link opens in a new window

40. Resuscitation Council UK. COVID-19 resources: newborn life support. Aug 2020 [internet publication].Full text external link opens in a new window

41. Centers for Disease Control and Prevention. Care for breastfeeding women. Interim guidance on breastfeeding and breast milk feeds in the context of COVID-19. Dec 2020 [internet publication].Full text external link opens in a new window

42. Chambers C, Krogstad P, Bertrand K, et al. Evaluation for SARS-CoV-2 in Breast Milk From 18 Infected Women. JAMA. 2020 Oct 6;324(13):1347-8.Full text external link opens in a new window Abstract external link opens in a new window

43. Elliott J, Bodinier B, Whitaker M, et al. COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors. Eur J Epidemiol. 2021 Mar;36(3):299-309.Full text external link opens in a new window Abstract external link opens in a new window

44. American Academy of Dermatology. Clinical guidance for COVID-19. 2020 [internet publication].Full text external link opens in a new window

45. National Institute for Health and Care Excellence. COVID-19 rapid guideline: dermatological conditions treated with drugs affecting the immune response. Apr 2021 [internet publication].Full text external link opens in a new window

46. Gadarowski MB, Balogh EA, Bashyam AM, et al. Examining recommendations for the use of biologics and other systemic therapies during COVID-19: a review and comparison of available dermatology guidelines and patient registries. J Dermatolog Treat. Oct 2020 [internet publication].Full text external link opens in a new window Abstract external link opens in a new window

47. Vultaggio A, Agache I, Akdis CA, et al. Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement. Allergy. 2020 Nov;75(11):2764-74.Abstract external link opens in a new window

48. International Psoriasis Council. IPC statement on the coronavirus (COVID-19) outbreak. Sep 2020 [internet publication].Full text external link opens in a new window

49. European Association of Dermatology and Venereology (EADV). Management of psoriasis patients under systemic treatments. April 2020 [internet publication].Full text external link opens in a new window

50. International Eczema Council. IEC statement on COVID-19. 2020 [internet publication].Full text external link opens in a new window

51. Erskine D. Using COVID-19 vaccines in patient taking immunosuppressive medicines. Feb 2021 [internet publication].Full text external link opens in a new window

52. Gelfand JM, Armstrong AW, Bell S, et al. National Psoriasis Foundation COVID-19 Task Force Guidance Statements. Apr 2021 [internet publication].Full text external link opens in a new window Abstract external link opens in a new window

53. Kasperkiewicz M, Schmidt E, Fairley JA, et al. Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic. J Eur Acad Dermatol Venereol. 2020 Jul;34(7):e302-e303.Full text external link opens in a new window Abstract external link opens in a new window

54. Wollenberg A, Flohr C, Simon D, et al. European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitis. J Eur Acad Dermatol Venereol. 2020 Jun;34(6):e241-e242.Full text external link opens in a new window Abstract external link opens in a new window

55. British Association of Dermatologists. Dermatology advice regarding medication acting on the immune system: adults, paediatrics and young people. Nov 2020 [internet publication].Full text external link opens in a new window

56. National Institute for Health and Care Excellence. COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response. Mar 2021 [internet publication].Full text external link opens in a new window

57. American Association for the Study of Liver Diseases. Clinical insights for hepatology and liver transplant providers during the COVID-19 pandemic. Mar 2021 [internet publication].Full text external link opens in a new window

58. Boettler T, Marjot T, Newsome PN, et al. Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic. JHEP Rep. 2020 Oct;2(5):100169.Full text external link opens in a new window Abstract external link opens in a new window

59. Erskine D. Using COVID-19 vaccines in patient taking immunosuppressive medicines. Feb 2021 [internet publication].Full text external link opens in a new window

60. NHS England. Clinical guide for triaging patients with lower gastrointestinal symptoms. Jun 2020 [internet publication].Full text external link opens in a new window

61. National Institute for Health and Care Excellence. Suspected cancer: recognition and referral. Jan 2021 [internet publication].Full text external link opens in a new window

62. Gralnek IM, Hassan C, Beilenhoff U, et al. ESGE and ESGENA position statement on gastrointestinal endoscopy and the COVID-19 pandemic. Endoscopy. 2020 Jun;52(6):483-90.Full text external link opens in a new window Abstract external link opens in a new window

63. Chiu PW, Ng SC, Inoue H, et al. Practice of endoscopy during COVID-19 pandemic: position statements of the Asian Pacific Society for Digestive Endoscopy (APSDE-COVID statements). Gut. 2020 Jun;69(6):991-96.Full text external link opens in a new window Abstract external link opens in a new window

64. Gralnek I, Hassan C, Beilenhoff U, et al. ESGE and ESGENA Position Statement on gastrointestinal endoscopy and COVID-19: An update on guidance during the post-lockdown phase and selected results from a membership survey. Endoscopy. 2020 Oct;52(10):891-8.Full text external link opens in a new window Abstract external link opens in a new window

65. Sultan S, Siddique SM, Altayar O, et al. AGA Institute Rapid Review and Recommendations on the Role of Pre-Procedure SARS-CoV2 Testing and Endoscopy. Gastroenterology. 2020 Nov;159(5):1935-48.e5.Full text external link opens in a new window Abstract external link opens in a new window

66. Walsh CM, Fishman DS, Lerner DG, et al. Pediatric Endoscopy in the Era of Coronavirus Disease 2019: A North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper. J Pediatr Gastroenterol Nutr. 2020 Jun;70(6):741-50.Full text external link opens in a new window Abstract external link opens in a new window

67. Wong GL, Wong VW, Thompson A, et al. Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement. Lancet Gastroenterol Hepatol. 2020 Aug;5(8):776-87.Full text external link opens in a new window Abstract external link opens in a new window

68. World Health Organization. Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19). Feb 2020 [internet publication].Full text external link opens in a new window

69. Ng WH, Tipih T, Makoah N, et al. Comorbidities in SARS-CoV-2 patients: a systematic review and meta-analysis. mBio. 2021 Feb 9;12(1):e03647-20.Full text external link opens in a new window Abstract external link opens in a new window

70. Pinato DJ, Zambelli A, Aguilar-Company J, et al. Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients. Cancer Discov. 2020 Oct 1;10(10):1465-74.Full text external link opens in a new window Abstract external link opens in a new window

71. Jee J, Foote MB, Lumish M, et al. Chemotherapy and COVID-19 Outcomes in Patients With Cancer. J Clin Oncol. 2020 Aug 14;JCO2001307.Full text external link opens in a new window Abstract external link opens in a new window

72. Lee LYW, Cazier JB, Starkey T, et al. COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. Lancet Oncol. 2020 Oct;21(10):1309-16.Full text external link opens in a new window Abstract external link opens in a new window

73. Wang Q, Berger NA, Xu R. Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 Infection. JAMA Oncol. 2021 Feb 1;7(2):220-7.Full text external link opens in a new window Abstract external link opens in a new window

74. Fair Health. Risk factors for COVID-19 mortality among privately insured patients: a claims data analysis. Nov 2020 [internet publication].Full text external link opens in a new window

75. National Institute for Health and Care Excellence. COVID-19 rapid guideline: delivery of systemic anticancer treatments. Feb 2021 [internet publication].Full text external link opens in a new window

76. Weinkove R, McQuilten ZK, Adler J, et al. Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance. Med J Aust. 2020 Jun;212(10):481-9.Full text external link opens in a new window Abstract external link opens in a new window

77. American Society for Clinical Oncology. COVID-19 patient care information. Apr 2021 [internet publication].Full text external link opens in a new window

78. National Institute for Health and Care Excellence. Interim treatment change options during the COVID-19 pandemic, endorsed by NHS England. Mar 2021 [internet publication].Full text external link opens in a new window

79. European Society for Medical Oncology. Cancer patient management during the COVID-19 pandemic. 2021 [internet publication].Full text external link opens in a new window

80. Curigliano G, Banerjee S, Cervantes A, et al. Managing cancer patients during the COVID-19 pandemic: An ESMO Interdisciplinary Expert Consensus. Ann Oncol. 2020 Oct;31(10):1320-35.Full text external link opens in a new window Abstract external link opens in a new window

81. Marron JM, Joffe S, Jagsi R, et al. Ethics and resource scarcity: ASCO recommendations for the oncology community during the COVID-19 pandemic. J Clin Oncol. 2020 Jul 1;38(19):2201-5.Full text external link opens in a new window Abstract external link opens in a new window

82. COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Apr 2021 [internet publication].Full text external link opens in a new window

83. American College of Cardiology. Delivery of Cardio-Oncology Care During the COVID-19 Pandemic. June 2020 [internet publication].Full text external link opens in a new window

84. National Institute for Health and Care Excellence. COVID-19 rapid guideline: delivery of radiotherapy. Feb 2021 [internet publication].Full text external link opens in a new window

85. Yahalom J, Dabaja BS, Ricardi U, et al. ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic. Blood. 2020 May 21;135(21):1829-32.Full text external link opens in a new window Abstract external link opens in a new window

86. Guckenberger M, Belka C, Bezjak A, et al. Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement. Radiother Oncol. 2020 May;146:223-9.Full text external link opens in a new window Abstract external link opens in a new window

87. Liao Z, Rivin Del Campo E, Salem A, et al. Optimizing lung cancer radiation treatment worldwide in COVID-19 outbreak. Lung Cancer. 2020 Aug;146:230-5.Full text external link opens in a new window Abstract external link opens in a new window

88. Mehanna H, Hardman JC, Shenson JA, et al. Recommendations for head and neck surgical oncology practice in a setting of acute severe resource constraint during the COVID-19 pandemic: an international consensus. Lancet Oncol. 2020 Jul;21(7):e350-9.Full text external link opens in a new window Abstract external link opens in a new window

89. COVID-19 and people with neuromuscular disorders: World Muscle Society position and advice. Nov 2020 [internet publication].Full text external link opens in a new window

90. Mehta N, Kalra A, Nowacki AS, et al. Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020 Sep 1;5(9):1020-102.Full text external link opens in a new window Abstract external link opens in a new window

91. Reynolds HR, Adhikari S, Pulgarin C, et al. Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19. N Engl J Med. 2020 Jun 18;382(25):2441-8.Full text external link opens in a new window Abstract external link opens in a new window

92. Mancia G, Rea F, Ludergnani M, et al. Renin-angiotensin-aldosterone system blockers and the risk of Covid-19. N Engl J Med. 2020 Jun 18;382(25):2431-40.Full text external link opens in a new window Abstract external link opens in a new window

93. World Health Organization. COVID-19 and the use of angiotensin-converting enzyme inhibitors and receptor blockers. Scientific brief. May 2020 [internet publication].Full text external link opens in a new window

94. Flacco ME, Acuti Martellucci C, Bravi F, et al. Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis. Heart. 2020 Oct;106(19):1519-24.Full text external link opens in a new window Abstract external link opens in a new window

95. Trifirò G, Massari M, Da Cas R, et al. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients. Drug Saf. 2020 Dec;43(12):1297-308.Full text external link opens in a new window Abstract external link opens in a new window

96. Hippisley-Cox J, Young D, Coupland C, et al. Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people. Heart. 2020 Oct;106(19):1503-11.Full text external link opens in a new window Abstract external link opens in a new window

97. Sablerolles RSG, Hogenhuis FEF, Lafeber M, et al. No association between use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers prior to hospital admission and clinical course of COVID-19 in the COvid MEdicaTion (COMET) study. Br J Clin Pharmacol. 28 Jan 2021 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

98. Cohen JB, Hanff TC, William P, et al. Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial. Lancet Respir Med. 2021 Mar;9(3):275-84.Full text external link opens in a new window Abstract external link opens in a new window

99. Lopes RD, Macedo AVS, de Barros E Silva PGM, et al. Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial. JAMA. 2021 Jan 19;325(3):254-64.Abstract external link opens in a new window

100. British Cardiovascular Society and British Society for Heart Failure. BSH & BCS joint statement on ACEi or ARB in relation to COVID-19. Mar 2020 [internet publication].Full text external link opens in a new window

101. European Society of Cardiology Council on Hypertension. Position statement of the ESC Council on Hypertension on ACE-inhibitors and angiotensin receptor blockers. Mar 2020 [internet publication].Full text external link opens in a new window

102. American Heart Association, Heart Failure Society of America, American College of Cardiology. Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician. Mar 2020 [internet publication].Full text external link opens in a new window

103. Kario K, Morisawa M, Sukonthasarn A, et al. COVID-.19 and hypertension-evidence and practical management: Guidance from the HOPE Asia Network. J Clin Hypertens (Greenwich). 2020 Jul;22(7):1109-19.Full text external link opens in a new window Abstract external link opens in a new window

104. Lee SW, Ha EK, Yeniova AO, et al. Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching. Gut. 2021 Jan;70(1):76-84.Full text external link opens in a new window Abstract external link opens in a new window

105. World Health Organization. Guiding principles for immunization activities during the COVID-19 pandemic: interim guidance, 26 March 2020. Mar 2020 [internet publication].Full text external link opens in a new window

106. Centers for Disease Control and Prevention. Schedule changes during the COVID-19 pandemic. Feb 2021 [internet publication].Full text external link opens in a new window

107. Public Health England. Statement from Joint Committee on Vaccination and Immunisation on immunisation prioritisation. Apr 2020 [internet publication].Full text external link opens in a new window

108. Santoli JM, Lindley MC, DeSilva MB, et al. Effects of the COVID-19 pandemic on routine pediatric vaccine ordering and administration - United States, 2020. MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):591-3.Full text external link opens in a new window Abstract external link opens in a new window

109. American Academy of Pediatrics. Guidance on providing pediatric well-care during COVID-19. Jan 2021 [internet publication].Full text external link opens in a new window

110. Grohskopf LA, Alyanak E, Broder KR, et al. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2020–21 Influenza Season. MMWR Recomm Rep. 2020 Aug 21;69(8):1-24.Full text external link opens in a new window Abstract external link opens in a new window

111. Public Health England. Clinical guidance for healthcare professionals on maintaining immunisation programmes during COVID-19: supported by the Royal College of General Practitioners (RCGP) and the Royal College of Paediatrics and Child Health (RCPCH). Jun 2020 [internet publication].Full text external link opens in a new window

112. Public Health England. Vaccine update: issue 312, October 2020, flu special edition. Oct 2020 [internet publication].Full text external link opens in a new window

113. Joint Committee of Vaccination and Immunisation: statement on the delivery of the HPV vaccine. July 2020 [internet publication].Full text external link opens in a new window

114. NHS England. Palivizumab passive immunisation against respiratory syncytial virus (RSV) in at-risk pre-term infants. October 2020 [internet publication].Full text external link opens in a new window

115. Anticoagulation Forum. Managing anticoagulation during the COVID-19 pandemic: frequently asked questions. Mar 2020 [internet publication].Full text external link opens in a new window

116. Medicines and Healthcare products Regulatory Agency. Warfarin and other anticoagulants - monitoring of patients during the COVID-19 pandemic. October 2020 [internet publication].Full text external link opens in a new window

117. National Institutes of Health. Coronavirus disease 2019 (COVID-19) treatment guidelines: antithrombotic therapy in patients with COVID-19. Feb 2021 [internet publication].Full text external link opens in a new window

118. National Institute for Health and Care Excellence. COVID-19 rapid guideline: managing COVID-19. Apr 2021 [internet publication].Full text external link opens in a new window

119. Speed V, Patel RK, Byrne R, et al. A perfect storm: Root cause analysis of supra-therapeutic anticoagulation with vitamin K antagonists during the COVID-19 pandemic. Thromb Res. 2020 Aug;192:73-74.Full text external link opens in a new window Abstract external link opens in a new window

120. American Psychiatric Association. Practice guidance for COVID-19. Oct 2020 [internet publication].Full text external link opens in a new window

121. Center for the Study of Traumatic Stress. Taking care of patients during the coronavirus outbreak: a guide for psychiatrists. 2020 [internet publication].Full text external link opens in a new window

122. Substance Abuse and Mental Health Services Administration. Coronavirus (COVID-19). Feb 2021 [internet publication].Full text external link opens in a new window

123. Public Health England. COVID-19: guidance for commissioners and providers of services for people who use drugs or alcohol. Apr 2021 [internet publication].Full text external link opens in a new window

124. Royal College of Psychiatrists. COVID-19: providing medication. 2020 [internet publication].Full text external link opens in a new window

125. Kahl KG, Correll CU. Management of patients with severe mental illness during the coronavirus disease 2019 pandemic. JAMA Psychiatry. 2020 Sep 1;77(9):977-8.Full text external link opens in a new window Abstract external link opens in a new window

126. Yalçın N, Ak S, Demirkan K. Do psychotropic drugs used during COVID-19 therapy have an effect on the treatment process? Eur J Hosp Pharm. 2021 Jan;28(1):e2.Full text external link opens in a new window Abstract external link opens in a new window

127. Mental Health Foundation. The COVID-19 pandemic, financial inequality and mental health. May 2020 [internet publication].Full text external link opens in a new window

128. Li L, Li F, Fortunati F, et al. Association of a Prior Psychiatric Diagnosis With Mortality Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Infection. JAMA Netw Open. 2020;3(9):e2023282.Full text external link opens in a new window Abstract external link opens in a new window

129. Lee SW, Yang JM, Moon SY, et al. Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study. Lancet Psychiatry. 2020 Dec;7(12):1025-31.Full text external link opens in a new window Abstract external link opens in a new window

130. Jeon HL, Kwon JS, Park SH, et al. Association of mental disorders with SARS-CoV-2 infection and severe health outcomes: nationwide cohort study. Br J Psychiatry. 2021 Jan 7;1-8 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

131. Nemani K, Li C, Olfson M, et al. Association of Psychiatric Disorders With Mortality Among Patients With COVID-19. JAMA Psychiatry. 2021 Jan 27 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

132. Livingston G, Rostamipour H, Gallagher P, et al. Prevalence, management, and outcomes of SARS-CoV-2 infections in older people and those with dementia in mental health wards in London, UK: a retrospective observational study. Lancet Psychiatry. 2020 Dec;7(12):1054-63.Full text external link opens in a new window Abstract external link opens in a new window

133. Taquet M, Luciano S, Geddes JR, et al. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2021 Feb;8(2):130-40.Full text external link opens in a new window Abstract external link opens in a new window

134. Czeisler MÉ , Lane RI, Petrosky E, et al. Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic — United States, June 24–30, 2020. MMWR Morb Mortal Wkly Rep 2020 Aug 14;69:1049–57.Full text external link opens in a new window

135. Ettman CK, Abdalla SM, Cohen GH, et al. Prevalence of Depression Symptoms in US Adults Before and During the COVID-19 Pandemic. JAMA Netw Open. 2020 Sep 1;3(9):e2019686.Full text external link opens in a new window Abstract external link opens in a new window

136. Vahratian A, Blumberg SJ, Terlizzi EP, et al. Symptoms of anxiety or depressive disorder and use of mental health care among adults during the COVID-19 pandemic - United States, August 2020-February 2021. MMWR Morb Mortal Wkly Rep. 2021 Apr 2;70(13):490-4.Full text external link opens in a new window Abstract external link opens in a new window

137. Pan KY, Kok AA, Eikelenboom M, et al. The mental health impact of the COVID-19 pandemic on people with and without depressive, anxiety, or obsessive-compulsive disorders: a longitudinal study of three Dutch case-control cohorts. Lancet Psychiatry. 2021 Feb;8(2):121-9.Full text external link opens in a new window Abstract external link opens in a new window

138. Wong SYS, Zhang D, Sit RWS, et al. Impact of COVID-19 on loneliness, mental health, and health service utilisation: a prospective cohort study of older adults with multimorbidity in primary care. Br J Gen Pract. 2020 Oct 29;70(700):e817-e824.Full text external link opens in a new window Abstract external link opens in a new window

139. Iob E, Steptoe A, Fancourt D. Abuse, self-harm and suicidal ideation in the UK during the COVID-19 pandemic. Br J Psychiatry. 2020 Oct;217(4):543-6.Full text external link opens in a new window Abstract external link opens in a new window

140. Public Health England. COVID-19: mental health and wellbeing surveillance report. Important findings so far. Apr 2021 [internet publication].Full text external link opens in a new window

141. O'Connor RC, Wetherall K, Cleare S, et al. Mental health and wellbeing during the COVID-19 pandemic: longitudinal analyses of adults in the UK COVID-19 Mental Health & Wellbeing study. Br J Psychiatry. 2020 Oct 21:1-17 [internet publication].Full text external link opens in a new window Abstract external link opens in a new window

142. Carr MJ, Steeg S, Webb RT, et al. Effects of the COVID-19 pandemic on primary care-recorded mental illness and self-harm episodes in the UK: a population-based cohort study. Lancet Public Health. 2021 Feb;6(2):e124-35.Full text external link opens in a new window Abstract external link opens in a new window

143. Wathelet M, Duhem S, Vaiva G, et al. Factors Associated With Mental Health Disorders Among University Students in France Confined During the COVID-19 Pandemic. JAMA Netw Open. 2020 Oct 1;3(10):e2025591.Full text external link opens in a new window Abstract external link opens in a new window

144. Pirkis J, John A, Shin S, et al. Suicide trends in the early months of the COVID-19 pandemic: an interrupted time-series analysis of preliminary data from 21 countries. Lancet Psychiatry. 13 April 2021 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

145. The Childhood Trust. Children in lockdown: the consequences of the coronavirus crisis for children living in poverty. Jun 2020 [internet publication].Full text external link opens in a new window

146. American Academy of Pediatrics. Interim Guidance on Supporting the Emotional and Behavioral Health Needs of Children, Adolescents, and Families During the COVID-19 Pandemic. Mar 2021 [internet publication]Full text external link opens in a new window

147. Bignardi G, Dalmaijer ES, Anwyl-Irvine AL, et al. Longitudinal increases in childhood depression symptoms during the COVID-19 lockdown. Arch Dis Child. 2020 Dec 9 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

148. Loades ME, Chatburn E, Higson-Sweeney N, et al. Rapid systematic review: the impact of social isolation and loneliness on the mental health of children and adolescents in the context of COVID-19. J Am Acad Child Adolesc Psychiatry. 2020 Nov;59(11):1218-39.Full text external link opens in a new window Abstract external link opens in a new window

149. NHS Digital. Mental Health of Children and Young People in England, 2020: Wave 1 follow up to the 2017 survey. October 2020 [internet publication].Full text external link opens in a new window

150. Leeb RT, Bitsko RH, Radhakrishnan L, et al. Mental Health-Related Emergency Department Visits Among Children Aged <18 Years During the COVID-19 Pandemic - United States, January 1-October 17, 2020. MMWR Morb Mortal Wkly Rep. 2020 Nov 13;69(45):1675-80.Full text external link opens in a new window Abstract external link opens in a new window

151. Verlenden J, Pampati S, Rasberry C, et al. Association of children’s mode of school instruction with child and parent experiences and well-being during the COVID-19 pandemic — COVID Experiences Survey, United States, October 8-November 13, 2020. MMWR Morb Mortal Wkly Rep. 2021 Mar 19;70(11):369-76.Full text external link opens in a new window Abstract external link opens in a new window

152. Kisely S, Warren N, McMahon L, et al. Occurrence, prevention, and management of the psychological effects of emerging virus outbreaks on healthcare workers: rapid review and meta-analysis. BMJ. 2020 May 5;369:m1642.Full text external link opens in a new window Abstract external link opens in a new window

153. Schwartz R, Sinskey JL, Anand U, et al. Addressing Postpandemic Clinician Mental Health : A Narrative Review and Conceptual Framework. Ann Intern Med. 2020 Dec 15;173(12):981-8.Full text external link opens in a new window Abstract external link opens in a new window

154. Barello S, Palamenghi L, Graffigna G. Burnout and somatic symptoms among frontline healthcare professionals at the peak of the Italian COVID-19 pandemic. Psychiatry Res. 2020 Aug;290:113129.Full text external link opens in a new window Abstract external link opens in a new window

155. NHS England. NHS Staff Survey Results. 2020 [internet publication].Full text external link opens in a new window

156. Centers for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19): coping with stress. Jan 2021 [internet publication].Full text external link opens in a new window

157. Centers for Disease Control and Prevention. Emergency responders: tips for taking care of yourself. Mar 2018 [internet publication].Full text external link opens in a new window

158. World Health Organization. WHO briefing note: mental health and psychosocial considerations during the COVID-19 outbreak. Mar 2020 [internet publication].Full text external link opens in a new window

159. National Institute for Health and Care Excellence. COVID-19 rapid guideline: children and young people who are immunocompromised. Aug 2020 [internet publication].Full text external link opens in a new window

160. Rosenthal CM, Thompson LA. Child Abuse Awareness Month during the coronavirus disease 2019 pandemic. JAMA Pediatr. 2020 Aug 1;174(8):812.Full text external link opens in a new window Abstract external link opens in a new window

161. Sidpra J, Abomeli D, Hameed B, et al. Rise in the incidence of abusive head trauma during the COVID-19 pandemic. Arch Dis Child. 2021 Mar;106(3):e14.Full text external link opens in a new window Abstract external link opens in a new window

162. American Academy of Pediatrics. Caring for children and youth with special health care needs during the COVID-19 pandemic. Feb 2021 [internet publication].Full text external link opens in a new window

163. Klein JD, Koletzko B, El-Shabrawi MH, et al. Promoting and supporting children's health and healthcare during COVID-19 - International Paediatric Association Position Statement. Arch Dis Child. 2020 Jul;105(7):620-24.Full text external link opens in a new window Abstract external link opens in a new window

164. Royal College of Paediatrics and Child Health. Safeguarding, looked after children and vulnerable children processes in England, Wales and Northern Ireland. Apr 2021 [internet publication].Full text external link opens in a new window

165. Medicines and Healthcare products Regulatory Agency. Valproate Pregnancy Prevention Programme: temporary advice for management during coronavirus (COVID-19). May 2020 [internet publication].Full text external link opens in a new window

166. Lakkireddy DR, Chung MK, Gopinathannair R, et al. Guidance for cardiac electrophysiology during the coronavirus (COVID-19) pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association. Circulation. 2020 May 26;141(21):e823-31.Full text external link opens in a new window Abstract external link opens in a new window

167. Zaman S, MacIsaac AI, Jennings GLR, et al. Cardiovascular disease and COVID-19: Australian/New Zealand consensus statement. Med J Aust. 2020 Apr 3;213(4):182-7.Full text external link opens in a new window Abstract external link opens in a new window

168. Kumar S, Haqqani H, Wynn G, et al. Position Statement on the Management of Cardiac Electrophysiology and Cardiac Implantable Electronic Devices in Australia during the COVID-19 Pandemic: A Living Document. Heart, Lung and Circulation. 2020 Jun 01;29(6):E57-E68.Full text external link opens in a new window

169. Association of Laparoscopic Surgeons of Great Britain and Northern Ireland. Laparoscopy in the COVID-19 environment - ALSGBI position statement. Apr 2020 [internet publication].Full text external link opens in a new window

170. Pavan N, Crestani A, Albrate A, et al. Risk of Virus Contamination Through Surgical Smoke During Minimally Invasive Surgery: A Systematic Review of the Literature on a Neglected Issue Revived in the COVID-19 Pandemic Era. Eur Urol Focus. 2020 Sep 15;6(5):1058-69.Full text external link opens in a new window Abstract external link opens in a new window

171. de Leeuw RA, Burger NB, Ceccaroni M, et al. COVID-19 and Laparoscopic Surgery: Scoping Review of Current Literature and Local Expertise. JMIR Public Health Surveill. 2020 Jun 23;6(2):e18928.Full text external link opens in a new window Abstract external link opens in a new window

172. Siah KTH, Rahman MM, Ong AML, et al. The Practice of Gastrointestinal Motility Laboratory During COVID-19 Pandemic: Position Statements of the Asian Neurogastroenterology and Motility Association (ANMA-GML-COVID-19 Position Statements). J Neurogastroenterol Motil. 2020 Jul 30;26(3):299-310.Full text external link opens in a new window Abstract external link opens in a new window

173. National Institute for Health and Care Excellence. COVID-19 rapid guideline: rearranging planned care in hospitals and diagnostic services. July 2020 [internet publication].Full text external link opens in a new window

174. Royal College of Surgeons of England. Recovery of surgical services during and after COVID-19. May 2020 [internet publication].Full text external link opens in a new window

175. American College of Surgeons. Clinical issues and guidance. Nov 2020 [internet publication].Full text external link opens in a new window

176. Mouton C, Hirschmann MT, Ollivier M, et al. COVID-19 - ESSKA guidelines and recommendations for resuming elective surgery. J Exp Orthop. 2020 May 13;7(1):28.Full text external link opens in a new window Abstract external link opens in a new window

177. Parvizi J, Gehrke T, Krueger CA, et al. Resuming Elective Orthopaedic Surgery During the COVID-19 Pandemic: Guidelines Developed by the International Consensus Group (ICM). J Bone Joint Surg Am. 2020 Jul 15;102(14):1205-1212.Full text external link opens in a new window Abstract external link opens in a new window

178. Shah PB, Welt FGP, Mahmud E, et al. Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID-19 Pandemic: An ACC/SCAI Position Statement. JACC Cardiovasc Interv. 2020 Jun 22;13(12):1484-88.Full text external link opens in a new window Abstract external link opens in a new window

179. American College of Surgeons. COVID-19 Guidelines for Triage of Emergency General Surgery Patients. Dec 2020 [internet publication].Full text external link opens in a new window

180. NELA Project Team. The impact of COVID-19 on emergency laparotomy – an interim report of the national emergency laparotomy audit, 23 March 2020 – 30 September 2020. London: Royal College of Anaesthetists, 2021.Full text external link opens in a new window

181. Royal College of Psychiatrists. COVID-19: Eating disorder services. 2020 [internet publication].Full text external link opens in a new window

182. American Academy of Pediatrics. Obesity Management and Treatment During COVID-19. Dec 2020 [internet publication].Full text external link opens in a new window

183. Boelaert K, Visser WE, Taylor PN, et al. ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of hyperthyroidism and hypothyroidism. Eur J Endocrinol. 2020 Jul;183(1):G33-9.Full text external link opens in a new window Abstract external link opens in a new window

184. Boelaert K, Visser WE, Taylor PN, et al. ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of hyperthyroidism and hypothyroidism. Eur J Endocrinol. 2020 Jul;183(1):G33-9.Full text external link opens in a new window Abstract external link opens in a new window

185. Jeffery MM, D'Onofrio G, Paek H, et al. Trends in Emergency Department Visits and Hospital Admissions in Health Care Systems in 5 States in the First Months of the COVID-19 Pandemic in the US. JAMA Intern Med. 2020 Oct 1;180(10):1328-33.Full text external link opens in a new window Abstract external link opens in a new window

186. Baum A, Schwartz MD. Admissions to veterans affairs hospitals for emergency conditions during the COVID-19 pandemic. JAMA. 2020 Jun 5;324(1):96-9.Full text external link opens in a new window Abstract external link opens in a new window

187. Williams R, Jenkins DA, Ashcroft DM, et al. Diagnosis of physical and mental health conditions in primary care during the COVID-19 pandemic: a retrospective cohort study. Lancet Public Health. 2020 Oct;5(10):e543-e550.Full text external link opens in a new window Abstract external link opens in a new window

188. Topriceanu CC, Wong A, Moon JC, et al. Evaluating access to health and care services during lockdown by the COVID-19 survey in five UK national longitudinal studies. BMJ Open. 2021 Mar 18;11(3):e045813.Full text external link opens in a new window Abstract external link opens in a new window

189. Holt A, Gislason GH, Schou M, et al. New-onset atrial fibrillation: incidence, characteristics, and related events following a national COVID-19 lockdown of 5.6 million people. Eur Heart J. 2020 Jun 1;41(32):3072-9.Full text external link opens in a new window Abstract external link opens in a new window

190. Mafham MM, Spata E, Goldacre R, et al. COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England. Lancet. 2020 Aug 8;396(10248):381-9.Full text external link opens in a new window Abstract external link opens in a new window

191. Kwok CS, Gale CP, Kinnaird T, et al. Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction. Heart. 2020 Dec;106(23):1805-11.Full text external link opens in a new window Abstract external link opens in a new window

192. Wu J, Mamas MA, Mohamed MO, et al. Place and causes of acute cardiovascular mortality during the COVID-19 pandemic. Heart. 2021 Jan;107(2):113-9.Full text external link opens in a new window Abstract external link opens in a new window

193. Mesnier J, Cottin Y, Coste P, et al. Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in France: a registry study. Lancet Public Health. 2020 Oct;5(10):e536-e542.Full text external link opens in a new window Abstract external link opens in a new window

194. Mohammad MA, Koul S, Olivecrona GK, et al. Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic. Heart. Oct 2020 [internet publication].Full text external link opens in a new window Abstract external link opens in a new window

195. Rattka M, Dreyhaupt J, Winsauer C, et al. Effect of the COVID-19 pandemic on mortality of patients with STEMI: a systematic review and meta-analysis. Heart. 2020 Dec 17 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

196. Kamrath C, Mönkemöller K, Biester T, et al. Ketoacidosis in Children and Adolescents With Newly Diagnosed Type 1 Diabetes During the COVID-19 Pandemic in Germany. JAMA. 2020 Aug 25;324(8):801-4.Full text external link opens in a new window Abstract external link opens in a new window

197. Rabbone I, Schiaffini R, Cherubini V, et al. Has COVID-19 Delayed the Diagnosis and Worsened the Presentation of Type 1 Diabetes in Children? Diabetes Care. 2020 Aug 10 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

198. Unsworth R, Wallace S, Oliver NS, et al. New-Onset Type 1 Diabetes in Children During COVID-19: Multicenter Regional Findings in the U.K. Diabetes Care. 2020 Aug 17 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

199. Hatoun J, Correa ET, Donahue SMA, et al. Social Distancing for COVID-19 and Diagnoses of Other Infectious Diseases in Children. Pediatrics. 2020 Oct;146(4):e2020006460.Full text external link opens in a new window Abstract external link opens in a new window

200. Olsen SJ, Azziz-Baumgartner E, Budd AP, et al. Decreased Influenza Activity During the COVID-19 Pandemic — United States, Australia, Chile, and South Africa, 2020. MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1305–9.Full text external link opens in a new window Abstract external link opens in a new window

201. Kaufman HW, Chen Z, Niles J, et al. Changes in the Number of US Patients With Newly Identified Cancer Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic. JAMA Netw Open. 2020 Aug 3;3(8):e2017267.Full text external link opens in a new window Abstract external link opens in a new window

202. Patt D, Gordan L, Diaz M, et al. The Impact of COVID-19 on Cancer Care: How the pandemic is delaying cancer diagnosis and treatment for American seniors. JCO Clin Cancer Inform. October 2020 [internet publication].Full text external link opens in a new window

203. Lai AG, Pasea L, Banerjee A, et al. Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study. BMJ Open. 2020 Nov 17;10(11):e043828.Full text external link opens in a new window Abstract external link opens in a new window

204. Morris E, Goldacre R, Spata E, et al. Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study. Lancet Gastroenterol Hepatol. 2021 Mar;6(3):199-208.Full text external link opens in a new window Abstract external link opens in a new window

205. Fakih MG, Bufalino A, Sturm L, et al. Coronavirus disease 2019 (COVID-19) pandemic, central-line-associated bloodstream infection (CLABSI), and catheter-associated urinary tract infection (CAUTI): The urgent need to refocus on hardwiring prevention efforts. Infect Control Hosp Epidemiol. 19 Feb 2021 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

206. Royal College of Paediatrics and Child Health. Advice for parents during coronavirus. 2020 [internet publication].Full text external link opens in a new window

207. Hogan AB, Jewell BL, Sherrard-Smith E, et al. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study. Lancet Glob Health. 2020 Sep;8(9):e1132-e1141.Full text external link opens in a new window Abstract external link opens in a new window

208. Bofill Rodriguez M, Lethaby A, Farquhar C, et al. Interventions commonly available during pandemics for heavy menstrual bleeding: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2020 Jul 23;7:CD013651.Full text external link opens in a new window Abstract external link opens in a new window

209. Campanile FC, Podda M, Arezzo A, et al. Acute cholecystitis during COVID-19 pandemic: a multisocietary position statement. World J Emerg Surg. 2020 Jun 8;15(1):38.Full text external link opens in a new window Abstract external link opens in a new window

210. Lin L, Wang X, Ren J, et al. Risk factors and prognosis for COVID-19-induced acute kidney injury: a meta-analysis. BMJ Open. 2020 Nov 10;10(11):e042573.Full text external link opens in a new window Abstract external link opens in a new window

211. Lin L, Wang X, Ren J, et al. Risk factors and prognosis for COVID-19-induced acute kidney injury: a meta-analysis. BMJ Open. 2020 Nov 10;10(11):e042573.Full text external link opens in a new window Abstract external link opens in a new window

212. Nugent J, Aklilu A, Yamamoto Y, et al. Assessment of acute kidney injury and longitudinal kidney function after hospital discharge among patients with and without COVID-19. JAMA Netw Open. 2021 Mar 1;4(3):e211095.Full text external link opens in a new window Abstract external link opens in a new window

213. Nephrology Journal Club. Acute kidney injury. Mar 2020 [internet publication].Full text external link opens in a new window

214. NHS England. Coronavirus Specialty Guides. Clinical guide for acute kidney injury in hospitalised patients with COVID-19 outside the intensive care unit during the coronavirus pandemic. Apr 2020 [internet publication].Full text external link opens in a new window

215. National Institute for Health and Care Excellence. COVID-19 rapid guideline: dialysis service delivery. Sep 2020 [internet publication].Full text external link opens in a new window

216. Zeidan AM, Boddu PC, Patnaik MM, et al. Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts. Lancet Haematol. 2020 Aug;7(8):e601-e612.Full text external link opens in a new window Abstract external link opens in a new window

217. American Society of Hematology. COVID-19 and adult ALL: frequently asked questions. Jan 2021 [internet publication].Full text external link opens in a new window

218. Sun C, Pleyer C, Wiestner A. COVID-19 vaccines for patients with haematological conditions. Lancet Haematol. 2021 May;8(5):e312-4.Full text external link opens in a new window Abstract external link opens in a new window

219. Passamonti F, Cattaneo C, Arcaini L, et al. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. Lancet Haematol. 2020 Oct;7(10):e737-e745.Full text external link opens in a new window Abstract external link opens in a new window

220. National Cancer Research Institute Acute Myelogenous Leukaemia working party. Recommendations for the management of patients with AML during the COVID-19 outbreak. Oct 2020 [internet publication].Full text external link opens in a new window

221. Sun C, Pleyer C, Wiestner A. COVID-19 vaccines for patients with haematological conditions. Lancet Haematol. 2021 May;8(5):e312-4.Full text external link opens in a new window Abstract external link opens in a new window

222. Arlt W, Baldeweg SE, Pearce SHS, et al. Endocrinology in the time of COVID-19: management of adrenal insufficiency. Eur J Endocrinol. 2020 Jul;183(1):G25-32.Full text external link opens in a new window Abstract external link opens in a new window

223. Royal College of Ophthalmologists. Medical Retinal Management Plans during COVID-19. September 2020 [internet publication].Full text external link opens in a new window

224. British Society for Allergy and Immunology. Modifications for adult allergy services during the COVID-19 pandemic. April 2020 [internet publication].Full text external link opens in a new window

225. Cardinale F, Ciprandi G, Barberi S, et al. Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic. Ital J Pediatr. 2020 Jun 16;46(1):84.Full text external link opens in a new window Abstract external link opens in a new window

226. Royal College of Ophthalmologists. Management plans for children and young people with eye and vision conditions during COVID-19. April 2020 [internet publication].Full text external link opens in a new window

227. Shah BN, Schlosshan D, McConkey HZR, et al. Outpatient management of heart valve disease following the COVID-19 pandemic: implications for present and future care. Heart. 2020 Oct;106(20):1549-54.Full text external link opens in a new window Abstract external link opens in a new window

228. American Society of Hematology. COVID-19 and aplastic anemia: frequently asked questions. May 2021 [internet publication].Full text external link opens in a new window

229. European Society for Blood and Marrow Transplantation. COVID-19 - Bone Marrow Failure and PNH Recommendations On behalf of the Severe Aplastic Anemia Working Party, European Group for Blood and Marrow Transplantation (EBMT). March 2020 [internet publication].Full text external link opens in a new window

230. NHS England. Eltrombopag as bridging therapy to haematopoietic stem cell transplant in severe or very severe aplastic anaemia during the COVID19 pandemic (in adults) (RPS 2006). Mar 2021 [internet publication].Full text external link opens in a new window

231. Global Initiative for Asthma. Global strategy for asthma management and prevention, 2021. [internet publication].Full text external link opens in a new window

232. Bloom C, Drake T, Docherty A, et al. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK. Lancet Respir Med. 4 Mar 2021 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

233. Aveyard P, Gao M, Lindson N, et al. Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study. Lancet Respir Med. 2021 Apr 1 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

234. National Institute for Health and Care Excellence. COVID-19 rapid guideline: severe asthma. Apr 2020 [internet publication].Full text external link opens in a new window

235. Licskai C, Yang CL, Ducharme FM, et al. Addressing therapeutic questions to help Canadian physicians optimize asthma management for their patients during the COVID-19 pandemic. Can J Resp Crit Care Sleep Med. 2020 Apr 30;4(2):73-6.Full text external link opens in a new window

236. American Lung Association. Asthma and COPD Mythbusting with Dr. Juanita Mora. March 2020 [internet publication].Full text external link opens in a new window

237. European Lung Foundation. COVID-19 and lung disease Q&A. Mar 2021 [internet publication].Full text external link opens in a new window

238. Centers for Disease Control and Prevention. Healthcare infection prevention and control FAQs for COVID-19. Mar 2021 [internet publication].Full text external link opens in a new window

239. British Thoracic Society. Advice for healthcare professionals treating people with asthma (adults) in relation to COVID-19. Nov 2020 [internet publication].Full text external link opens in a new window

240. Bloom C, Drake T, Docherty A, et al. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK. Lancet Respir Med. 4 Mar 2021 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

241. Broadhurst R, Peterson R, Wisnivesky JP, et al. Asthma in COVID-19 Hospitalizations: An Overestimated Risk Factor? Ann Am Thorac Soc. 2020 Dec;17(12):1645-8.Full text external link opens in a new window Abstract external link opens in a new window

242. Davies GA, Alsallakh MA, Sivakumaran S, et al. Impact of COVID-19 lockdown on emergency asthma admissions and deaths: national interrupted time series analyses for Scotland and Wales. Thorax. 2021 Mar 29 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

243. Shah SA, Quint JK, Nwaru BI, et al. Impact of COVID-19 national lockdown on asthma exacerbations: interrupted time-series analysis of English primary care data. Thorax. 2021 Mar 29 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

244. Cortese S, Asherson P, Sonuga-Barke E, et al. ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group. Lancet Child Adolesc Health. 2020 Jun;4(6):412-14.Full text external link opens in a new window Abstract external link opens in a new window

245. British Society of Gastroenterology. A joint statement on vaccination for Sars-CoV-2 in patients with liver disease. Mar 2021 [internet publication].Full text external link opens in a new window

246. American Society of Breast Surgeons. Recommendations for prioritisation, treatment and triage of patients with breast cancer during the COVID-19 pandemic. Apr 2020 [internet publication].Full text external link opens in a new window

247. Association of Breast Surgery. Recommendations on delivery of breast services during the COVID-19 pandemic. May 2020 [internet publication].Full text external link opens in a new window

248. Association of Breast Surgery and UK Breast Cancer Group. Joint statement on neoadjuvant chemotherapy during the COVID-19 pandemic. May 2020 [internet publication].Full text external link opens in a new window

249. Edmonds CE, Zuckerman SP, Conant EF. Management of Unilateral Axillary Lymphadenopathy Detected on Breast MRI in the Era of Coronavirus Disease (COVID-19) Vaccination. AJR Am J Roentgenol. 5 Feb 2021 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

250. Royal College of Paediatrics and Child Health. National guidance for the management of children with bronchiolitis and lower respiratory tract infections during COVID-19. May 2021 [internet publication].Full text external link opens in a new window

251. UK and Ireland Neuroendocrine Tumour Society. COVID-19 pandemic strategy for the interim management of patients with Neuroendocrine Tumours/Neuroendocrine Cancer. Apr 2020 [internet publication].Full text external link opens in a new window

252. International Liaison Committee on Resuscitation. COVID-19: practical guidance for implementation. 2020 [internet publication].Full text external link opens in a new window

253. Edelson DP, Sasson C, Chan PS, et al. Interim guidance for basic and advanced life support in adults, children, and neonates with suspected or confirmed COVID-19: from the Emergency Cardiovascular Care Committee and Get With the Guidelines® - Resuscitation Adult and Pediatric Task Forces of the American Heart Association in collaboration with the American Academy of Pediatrics, American Association for Respiratory Care, American College of Emergency Physicians, The Society of Critical Care Anesthesiologists, and American Society of Anesthesiologists: Supporting Organizations: American Association of Critical Care Nurses and National EMS Physicians. Circulation. 2020 Jun 23;141(25):e933-43.Full text external link opens in a new window Abstract external link opens in a new window

254. Resuscitation Council UK. Resuscitation Council UK statement on COVID-19 in relation to CPR and resuscitation in acute hospital settings. Apr 2020 [internet publication].Full text external link opens in a new window

255. Topjian A, Aziz K, Kamath-Rayne BD, et al. Interim guidance for basic and advanced life support in children and neonates with suspected or confirmed COVID-19. Pediatrics. 2020 May 4 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

256. Resuscitation of the drowned person in the era of COVID-19 disease: a common ground for recommendations, identification of research needs and a global call to action. Position Statement of the International Drowning Researchers' Alliance, International Life Saving Federation Medical Committee and International Maritime Rescue Federation. May 2020 [internet publication].Full text external link opens in a new window

257. Position Statement: cardiopulmonary resuscitation of patients with confirmed or suspected COVID-19 - 2020. Brazilian Association of Emergency Medicine (ABRAMEDE), Brazilian Society of Cardiology (SBC), Brazilian Association of Intensive Care Medicine (AMIB), and Brazilian Society of Anesthesiology (SBA). July 2020 [internet publication].Full text external link opens in a new window

258. Manto M, Dupre N, Hadjivassiliou M, et al. Management of Patients with Cerebellar Ataxia During the COVID-19 Pandemic: Current Concerns and Future Implications. Cerebellum. 2020 Aug;19(4):562-8.Full text external link opens in a new window Abstract external link opens in a new window

259. Bhatt AS, Jering KS, Vaduganathan M, et al. Clinical outcomes in patients with heart failure hospitalized with COVID-19. JACC Heart Fail. 2021 Jan;9(1):65-73.Full text external link opens in a new window Abstract external link opens in a new window

260. Rey JR, Caro-Codón J, Rosillo SO, et al. Heart failure in COVID-19 patients: prevalence, incidence and prognostic implications. 2020 Dec;22(12):2205-15.Full text external link opens in a new window Abstract external link opens in a new window

261. European Society of Cardiology. ESC guidance for the diagnosis and management of CV disease during the COVID-19 pandemic. Jun 2020 [internet publication].Full text external link opens in a new window

262. Centers for Disease Control and Prevention. Coronavirus disease 19 (COVID-19): information for people who are at higher risk for severe illness. Apr 2021 [internet publication].Full text external link opens in a new window

263. Fang X, Li S, Yu H, et al. Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis. Aging (Albany NY). 2020 Jul 13;12(13):12493-12503.Full text external link opens in a new window Abstract external link opens in a new window

264. Svensson P, Hofmann R, Häbel H, et al. Association between cardiometabolic disease and severe COVID-19: a nationwide case-control study of patients requiring invasive mechanical ventilation. BMJ Open. 2021 Feb 17;11(2):e044486.Full text external link opens in a new window Abstract external link opens in a new window

265. Biswas M, Rahaman S, Biswas TK, et al. Association of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis. Intervirology. 9 Dec 2020 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

266. National Institute for Health and Care Excellence. COVID-19 rapid guideline: chronic kidney disease. May 2020 [internet publication].Full text external link opens in a new window

267. International Society of Nephrology. Recommendations for the novel coronavirus 2019 epidemic. Apr 2020 [internet publication].Full text external link opens in a new window

268. Centers for Disease Control and Prevention. Interim additional guidance for infection prevention and control recommendations for patients with suspected or confirmed COVID-19 in outpatient hemodialysis facilities. Dec 2020 [internet publication].Full text external link opens in a new window

269. Shen Q, Wang M, Che R, et al. Consensus recommendations for the care of children receiving chronic dialysis in association with the COVID-19 epidemic. Pediatr Nephrol. 2020 Jul;35(7):1351-57.Full text external link opens in a new window Abstract external link opens in a new window

270. Scarfò L, Chatzikonstantinou T, Rigolin GM, et al. COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus. Leukemia. 2020 Sep;34(9):2354-63.Full text external link opens in a new window Abstract external link opens in a new window

271. American Society of Hematology. COVID-19 and CLL: frequently asked questions. Feb 2021 [internet publication].Full text external link opens in a new window

272. Di Ciaccio P, McCaughan G, Trotman J, et al. Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic. Intern Med J. 2020 Jun;50(6):667-79.Full text external link opens in a new window Abstract external link opens in a new window

273. Herishanu Y, Avivi I, Aharon A, et al. Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in patients with chronic lymphocytic leukemia. Blood. 16 April 2021 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

274. American Society of Hematology. COVID-19 and CML: frequently asked questions. Jan 2021 [internet publication].Full text external link opens in a new window

275. Noor FM, Islam M. Prevalence and associated risk factors of mortality among COVID-19 patients: a meta-analysis. J Community Health. 2020 Dec;45(6):1270-82.Full text external link opens in a new window Abstract external link opens in a new window

276. Aveyard P, Gao M, Lindson N, et al. Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study. Lancet Respir Med. 2021 Apr 1 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

277. The Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2021 GOLD REPORTS: 2021 global strategy for prevention, diagnosis and management of COPD. Dec 2020 [internet publication].Full text external link opens in a new window

278. The Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2021 GOLD REPORTS: 2021 global strategy for prevention, diagnosis and management of COPD. Dec 2020 [internet publication].Full text external link opens in a new window

279. National Institute for Health and Care Excellence. COVID-19 rapid guideline: community-based care of patients with chronic obstructive pulmonary disease (COPD). Apr 2020 [internet publication].Full text external link opens in a new window

280. British Thoracic Society. COPD and COVID-19 for healthcare professionals. Apr 2020 [internet publication].Full text external link opens in a new window

281. British Thoracic Society. Pulmonary rehabilitation resource pack. Jan 2021 [internet publication].Full text external link opens in a new window

282. Tan JY, Conceicao EP, Wee LE, et al. COVID-19 public health measures: a reduction in hospital admissions for COPD exacerbations. Thorax. 2020 Dec 3 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

283. Shanthanna H, Strand NH, Provenzano DA, et al. Caring for patients with pain during the COVID-19 pandemic: consensus recommendations from an international expert panel. Anaesthesia. 2020 Jul;75(7):935-44.Full text external link opens in a new window Abstract external link opens in a new window

284. Drake TM, Fairfield CJ, Pius R, et al. Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study. May 2021 [internet publication].Full text external link opens in a new window

285. Klimek L, Jutel M, Bousquet J, et al. Management of patients with chronic rhinosinusitis during the COVID-19 pandemic - An EAACI Position Paper. Allergy. 2021 Mar;76(3):677-88.Full text external link opens in a new window Abstract external link opens in a new window

286. Vultaggio A, Agache I, Akdis CA, et al. Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement. Allergy. 2020 Nov;75(11):2764-74.Abstract external link opens in a new window

287. Chandok N, Watt KD. Pain management in the cirrhotic patient: the clinical challenge. Mayo Clin Proc. 2010 May;85(5):451-8.Full text external link opens in a new window Abstract external link opens in a new window

288. Marjot T, Webb GJ, Barritt AS, et al. SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question. Lancet Gastroenterol Hepatol. 2021 Mar;6(3):156-8.Full text external link opens in a new window Abstract external link opens in a new window

289. British Society of Gastroenterology. A joint statement on vaccination for Sars-CoV-2 in patients with liver disease. Mar 2021 [internet publication].Full text external link opens in a new window

290. US Food and Drug Administration. Safety alert regarding use of fecal microbiota for transplantation and additional safety protections pertaining to SARS-CoV-2 and COVID-19. Mar 2020 [internet publication].Full text external link opens in a new window

291. Centers for Disease Control and Prevention. Fungal Diseases and COVID-19. Jan 2021 [internet publication].Full text external link opens in a new window

292. Trovato CM, Montuori M, Cucchiara S, et al. ESPGHAN 'biopsy-sparing' guidelines for celiac disease in children with low antitransglutaminase during COVID-19. Eur J Gastroenterol Hepatol. 2020 Dec;32(12):1523-26.Abstract external link opens in a new window

293. Centre for Evidence-Based Medicine. Are there any evidence-based ways of assessing dyspnoea (breathlessness) by telephone or video. Apr 2020 [internet publication].Full text external link opens in a new window

294. Centers for Disease Control and Prevention. Fungal Diseases and COVID-19. Jan 2021 [internet publication].Full text external link opens in a new window

295. Alsaied T, Aboulhosn JA, Cotts TB, et al. Coronavirus disease 2019 (COVID-19) pandemic implications in pediatric and adult congenital heart disease. J Am Heart Assoc. 2020 Jun 16;9(12):e017224.Full text external link opens in a new window Abstract external link opens in a new window

296. Diller GP, Gatzoulis MA, Broberg CS, et al. Coronavirus disease 2019 in adults with congenital heart disease: a position paper from the ESC working group of adult congenital heart disease, and the International Society for Adult Congenital Heart Disease. Eur Heart J. 2020 Dec 12 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

297. Radke RM, Frenzel T, Baumgartner H, et al. Adult congenital heart disease and the COVID-19 pandemic. Heart. 2020;106:1302-09.Full text external link opens in a new window

298. American College of Obstetricians and Gynecologists. COVID-19 FAQs for obstetrician-gynecologists, gynecology. Mar 2021 [internet publication].Full text external link opens in a new window

299. Faculty of Sexual and Reproductive Healthcare. FSRH CEU advice to support the provision of effective contraception during the COVID-19 outbreak. Mar 2020 [internet publication].Full text external link opens in a new window

300. Royal College of Obstetricians and Gynecologists, Faculty of Sexual and Reproductive Healthcare, and British Society of Abortion Care Providers Joint Guidance. Coronavirus (COVID-19) infection and abortion care. July 2020 [internet publication].Full text external link opens in a new window

301. British Society of Gastroenterology. Expanded consensus advice for the management of IBD during the COVID-19 pandemic. Mar 2021 [internet publication].Full text external link opens in a new window

302. Quraishi MN, Cooney R, Brookes MJ, et al. An urgent need to institute COVID-19 testing in patients with IBD experiencing flares. Front Gastroenterol. 2020 Mar 27;11(4):330-1.Full text external link opens in a new window Abstract external link opens in a new window

303. Zingone F, Savarino EV. Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak. Lancet Gastroenterol Hepatol. 2020 Jun;5(6):525.Full text external link opens in a new window Abstract external link opens in a new window

304. International Organization for the Study of Inflammatory Bowel Disease. Care of the IBD patient requiring hospitalization or surgery during the COVID-19 pandemic. May 2020 [internet publication].Full text external link opens in a new window

305. International Organisation for the study of inflammatory bowel disease. IOIBD recommendations: best practice guidance for when to restart IBD therapy in patients who have suspected or confirmed COVID-19. May 2020 [internet publication].Full text external link opens in a new window

306. Kennedy N, Goodhand JR, Bewshea C, et al. Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab. Gut. 2021 May;70(5):865-75.Full text external link opens in a new window Abstract external link opens in a new window

307. American Gastroenterological Association. Gastroenterology professional society guidance on endoscopic procedures during the COVID-19 pandemic. Mar 2020 [internet publication].Full text external link opens in a new window

308. Iacucci M, Cannatelli R, Labarile N, et al. Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period. Lancet Gastroenterol Hepatol. 2020 Jun;5(6):598-606.Full text external link opens in a new window Abstract external link opens in a new window

309. Remzi FH, Panis Y, Spinelli A, et al. International Organization for the Study of Inflammatory Bowel Disease recommendations for surgery in patients with inflammatory bowel disease during the COVID-19 pandemic. Dis Colon Rectum. 2020 Jul;63(7):870-3.Full text external link opens in a new window Abstract external link opens in a new window

310. Alexander J, Moran GW, Gaya DR, et al. SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement. Lancet Gastroenterol Hepatol. 2021 Mar;6(3):218-24.Full text external link opens in a new window Abstract external link opens in a new window

311. Newell-Price J, Nieman L, Reincke M, et al. Endocrinology in the time of COVID-19: Management of Cushing's syndrome. Eur J Endocrinol. 2020 Jul;183(1):G1-7.Full text external link opens in a new window Abstract external link opens in a new window

312. Pivonello R, Ferrigno R, Isidori A, et al. COVID-19 and Cushing's syndrome: recommendations for a special population with endogenous glucocorticoid excess. Lancet Diabetes Endocrinol. 2020 Aug;8(8):654-6.Full text external link opens in a new window Abstract external link opens in a new window

313. Pivonello R, Ferrigno R, Isidori A, et al. COVID-19 and Cushing's syndrome: recommendations for a special population with endogenous glucocorticoid excess. Lancet Diabetes Endocrinol. 2020 Aug;8(8):654-6.Full text external link opens in a new window Abstract external link opens in a new window

314. Papadavid E, Scarisbrick J, Ortiz Romero P, et al. Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines. J Eur Acad Dermatol Venereol. 2020 Aug;34(8):1633-6.Full text external link opens in a new window Abstract external link opens in a new window

315. National Institute for Health and Care Excellence. COVID-19 rapid guideline: cystic fibrosis. Oct 2020 [internet publication].Full text external link opens in a new window

316. Wang Q, Davis PB, Gurney ME, et al. COVID-19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US. Alzheimers Dement. 9 Feb 2021 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

317. European Academy of Neurology. Dementia Scientific Panel report - COVID-19. Apr 2020 [internet publication].Full text external link opens in a new window

318. McGurnaghan SJ, Weir A, Bishop J, et al. Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland. Lancet Diabetes Endocrinol. 2020 Dec 23 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

319. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9.Full text external link opens in a new window Abstract external link opens in a new window

320. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42.Full text external link opens in a new window Abstract external link opens in a new window

321. Barron E, Bakhai C, Kar P, et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endocrinol. 2020 Oct;8(10):813-22.Full text external link opens in a new window Abstract external link opens in a new window

322. Seiglie J, Platt J, Cromer SJ, et al. Diabetes as a Risk Factor for Poor Early Outcomes in Patients Hospitalized With COVID-19. Diabetes Care. 2020 Aug 26:dc201506.Full text external link opens in a new window Abstract external link opens in a new window

323. Gregory JM, Slaughter JC, Duffus SH, et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes. Diabetes Care. 2021 Feb;44(2):526-32.Full text external link opens in a new window Abstract external link opens in a new window

324. Longmore DK, Miller JE, Bekkering S, et al. Diabetes and overweight/obesity are independent, nonadditive risk factors for in-hospital severity of COVID-19: an international, multicenter retrospective meta-analysis. Diabetes Care. 15 Apr 2021 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

325. Holman N, Knighton P, Kar P, et al. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol. 2020 Oct;8(10):823–33.Full text external link opens in a new window Abstract external link opens in a new window

326. Gregory JM, Slaughter JC, Duffus SH, et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes. Diabetes Care. 2021 Feb;44(2):526-32.Full text external link opens in a new window Abstract external link opens in a new window

327. Schlesinger S, Neuenschwander M, Lang A, et al. Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis. Diabetologia. 28 Apr 2021 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

328. Bae SA, Kim SR, Kim MN, et al. Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis. Heart. Dec 2020 [internet publication].Full text external link opens in a new window Abstract external link opens in a new window

329. Association of British Clinical Diabetologists. Concise advice on inpatient diabetes during COVID19 - front door guidance. Nov 2020 [internet publication].Full text external link opens in a new window

330. Coppelli A, Giannarelli R, Aragona M, et al. Hyperglycemia at Hospital Admission Is Associated With Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 Study. Diabetes Care. 2020 Oct;43(10):2345-8.Full text external link opens in a new window Abstract external link opens in a new window

331. Klonoff DC, Messler JC, Umpierrez GE, et al. Association Between Achieving Inpatient Glycemic Control and Clinical Outcomes in Hospitalized Patients With COVID-19: A Multicenter, Retrospective Hospital-Based Analysis. Diabetes Care. 2020 Dec 15 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

332. American Diabetes Association. COVID-19: If you do get sick, know what to do. Mar 2020 [internet publication].Full text external link opens in a new window

333. Diabetes and Primary Care. At a glance fact sheet: COVID-19 and diabetes. Apr 2020 [internet publication].Full text external link opens in a new window

334. Bornstein SR, Rubino F, Khunti K, et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020 Jun;8(6):546-50.Full text external link opens in a new window Abstract external link opens in a new window

335. National Inpatient Diabetes Covid-19 Response Group. COncise adVice on Inpatient Diabetes (COVID:Diabetes): dexamethasone/glucocorticosteroid therapy in Covid-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes. Nov 2020 [internet publication].Full text external link opens in a new window

336. Dennis JM, Mateen BA, Sonabend R, et al. Type 2 Diabetes and COVID-19-Related Mortality in the Critical Care Setting: A National Cohort Study in England, March-July 2020. Diabetes Care. 2020 Oct 23:dc201444.Full text external link opens in a new window Abstract external link opens in a new window

337. Chen Y, Yang D, Cheng B, et al. Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication. Diabetes Care. 2020 Jul;43(7):1399-407.Full text external link opens in a new window Abstract external link opens in a new window

338. Mirani M, Favacchio G, Carrone F, et al. Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy. Diabetes Care. Oct 2020 [internet publication].Full text external link opens in a new window Abstract external link opens in a new window

339. Agarwal S, Schechter C, Southern W, et al. Preadmission Diabetes-Specific Risk Factors for Mortality in Hospitalized Patients With Diabetes and Coronavirus Disease 2019. Diabetes Care. 2020 Oct;43(10):2339-44.Full text external link opens in a new window Abstract external link opens in a new window

340. National Inpatient Diabetes Covid-19 Response Group. COncise adVice on Inpatient Diabetes (COVID:Diabetes): dexamethasone/glucocorticosteroid therapy in Covid-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes. Nov 2020 [internet publication].Full text external link opens in a new window

341. British Association of Dermatologists. Covid-19 (Coronavirus): statement on dry skin and frequent handwashing to reduce Covid-19 risk. Mar 2020 [internet publication].Full text external link opens in a new window

342. Leonardi M, Hummelshoj L, Johnson N. Advice regarding COVID-19 and endometriosis for patients and healthcare providers. May 2020 [internet publication].Full text external link opens in a new window

343. European Academy of Neurology. Impact of COVID-19 on management of epilepsy. Apr 2020 [internet publication].Full text external link opens in a new window

344. European Reference Network for Rare or Low Prevalence Complex Diseases. COVID-19 and epilepsy - ERN EpiCARE recommendations. Apr 2020 [internet publication].Full text external link opens in a new window

345. ENT UK. COVID-19 epistaxis management. Mar 2020 [internet publication].Full text external link opens in a new window

346. Rezel-Potts E, Douiri A, Chowienczyk PJ, et al. Antihypertensive medications and COVID-19 diagnosis and mortality: population-based case-control analysis in the United Kingdom. Br J Clin Pharmacol. 27 Apr 2021 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

347. Lopes RD, Macedo AVS, de Barros E Silva PGM, et al. Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial. JAMA. 2021 Jan 19;325(3):254-64.Abstract external link opens in a new window

348. British Society for Allergy and Clinical Immunology. Modifications for paediatric allergy services during COVID-19 pandemic. Mar 2020 [internet publication].Full text external link opens in a new window

349. Klimek L, Jutel M, Akdis C, et al. Handling of allergen immunotherapy in the COVID-19 pandemic: an ARIA-EAACI statement. Allergy. 2020 Jul;75(7):1546-54.Full text external link opens in a new window Abstract external link opens in a new window

350. Mackie SL, Brouwer E, Conway R, et al. Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspective. Lancet. 2021 Jan 1;3(1):E71-E82.Full text external link opens in a new window

351. NHS England. Tocilizumab for giant cell arteritis (GCA) during the COVID-19 pandemic (RPS 2007). Mar 2021 [internet publication].Full text external link opens in a new window

352. National Institute for Health and Care Excellence. COVID-19 rapid guideline: haematopoietic stem cell transplantation. Feb 2021 [internet publication].Full text external link opens in a new window

353. European Society for Blood and Marrow transplantation. COVID-19 and BMT. Feb 2021 [internet publication].Full text external link opens in a new window

354. American Society of Hematology. COVID-19 and multiple myeloma: frequently asked questions. Jan 2021 [internet publication].Full text external link opens in a new window

355. Sharma A, Bhatt NB, St Martin A, et al. Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study. Lancet Haematol. 2021 Mar;8(3):e185-93.Full text external link opens in a new window Abstract external link opens in a new window

356. Lupo-Stanghellini MT, Messina C, Marktel S, et al. Following-up allogeneic transplantation recipients during the COVID-19 pandemic. Lancet Haematol. 2020 May 22;S2352-3026(20)30176-9.Full text external link opens in a new window Abstract external link opens in a new window

357. Aydillo T, Gonzalez-Reiche AS, Aslam s, et al. Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer. N Engl J Med. 2020 Dec 24;383(26):2586-8.Full text external link opens in a new window Abstract external link opens in a new window

358. Dong J, Qin E, Xu J, et al. Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study. J Hepatol. 2020 Aug;73(2):451-3.Full text external link opens in a new window Abstract external link opens in a new window

359. Barry A, Apisarnthanarax S, O'Kane GM, et al. Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspective. Lancet Gastroenterol Hepatol. 2020 Aug;5(8):765-75.Full text external link opens in a new window Abstract external link opens in a new window

360. Narang A, Chan G, Aframian A, et al. Thirty-day mortality following surgical management of hip fractures during the COVID-19 pandemic: findings from a prospective multi-centre UK study. Int Orthop. 2020 Aug 29;1-9.Full text external link opens in a new window Abstract external link opens in a new window

361. Chlebeck JD, Birch CE, Blankstein M, et al. Nonoperative Geriatric Hip Fracture Treatment Is Associated With Increased Mortality: A Matched Cohort Study. J Orthop Trauma. 2019 Jul;33(7):346-50.Abstract external link opens in a new window

362. Vizcarra P, Pérez-Elías MJ, Quereda C, et al. Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort. Lancet HIV. 2020 Aug;7(8):e554-e564.Full text external link opens in a new window Abstract external link opens in a new window

363. Gervasoni C, Meraviglia P, Riva A, et al. Clinical features and outcomes of HIV patients with coronavirus disease 2019. Clin Infect Dis. 2020 Nov 19;71(16):2276-8.Full text external link opens in a new window Abstract external link opens in a new window

364. Byrd KM, Beckwith CG, Garland JM, et al. SARS-CoV-2 and HIV coinfection: clinical experience from Rhode Island, United States. J Int AIDS Soc. 2020 Jul 19;23(7):e25573.Full text external link opens in a new window Abstract external link opens in a new window

365. Del Amo J, Polo R, Moreno S, et al. Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy: A Cohort Study. Ann Intern Med. 2020 Oct 6;173(7):536-41.Full text external link opens in a new window Abstract external link opens in a new window

366. Tesoriero JM, Swain CAE, Pierce JL, et al. Assessment of Maternal and Neonatal Cord Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios. JAMA Pediatr. 29 Jan 2021 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

367. Spinelli M, Lynch K, Yun C, et al. SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study. Lancet HIV. 29 Apr 2021 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

368. Tesoriero JM, Swain CAE, Pierce JL, et al. Assessment of Maternal and Neonatal Cord Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios. JAMA Pediatr. 29 Jan 2021 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

369. Bhaskaran K, Rentsch CT, MacKenna B, et al. HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform. Lancet HIV. 2021 Jan;8(1):e24-32.Full text external link opens in a new window Abstract external link opens in a new window

370. Hadi YB, Naqvi SF, Kupec JT, et al. Characteristics and outcomes of COVID-19 in patients with HIV: a multicentre research network study. AIDS. 2020 Nov 1;34(13):F3-F8.Full text external link opens in a new window Abstract external link opens in a new window

371. Boulle A, Davies MA, Hussey H, et al. Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa. Clin Infect Dis. Aug 2020 [internet publication].Full text external link opens in a new window Abstract external link opens in a new window

372. US Department of Health and Human Services. Interim guidance for COVID-19 and persons with HIV. Feb 2021 [internet publication].Full text external link opens in a new window

373. European AIDS Clinical Society (EACS) and British HIV Association (BHIVA). EACS & BHIVA statement on risk of COVID-19 for people living with HIV (PLWH). Apr 2020 [internet publication].Full text external link opens in a new window

374. Infectious Disease Society of America and HIV Medicine Association. COVID-19: special considerations for people living with HIV. Dec 2020 [internet publication].Full text external link opens in a new window

375. European AIDS Clinical Society. COVID-19 and HIV. BHIVA, DAIG, EACS, GESIDA & Polish Scientific AIDS Society. Statement on risk of COVID-19 for people living with HIV (PLWH). May 2020 [internet publication].Full text external link opens in a new window

376. Guidance for the management of patients with lymphoma during the COVID19 health emergency: a statement from a panel of UK lymphoma experts. Mar 2020 [internet publication].Full text external link opens in a new window

377. American Society of Hematology. COVID-19 and Hodgkin lymphoma: frequently asked questions. Feb 2021 [internet publication].Full text external link opens in a new window

378. National Institute for Health and Care Excellence. COVID-19 rapid guideline: interstitial lung disease. May 2020 [internet publication].Full text external link opens in a new window

379. Canadian Thoracic Society. Optimizing Care for Patients with Interstitial Lung Disease during the COVID-19 pandemic. Aug 2020 [internet publication].Full text external link opens in a new window

380. American Society for Hematology. COVID-19 and ITP: frequently asked questions. Apr 2021 [internet publication].Full text external link opens in a new window

381. Centers for Disease Control and Prevention. Interim Guidance for Routine and Influenza Immunization Services During the COVID-19 Pandemic. Apr 2021 [internet publication].Full text external link opens in a new window

382. Stowe J, Tessier, E, Zhao H, et al. Interactions between SARS-CoV-2 and Influenza and the impact of coinfection on disease severity: A test negative design. Int J Epidemiol. 3 May 2021 [Epub ahead of print].Full text external link opens in a new window

383. Public Health England. COVID 19 deaths of people identified as having learning disabilities: summary. Nov 2020 [internet publication].Full text external link opens in a new window

384. Gleason J, Ross W, Alexander Fossi A, et al. The devastating impact of Covid-19 on individuals with intellectual disabilities in the United States. N Eng J Med. Mar 2021 [internet publication].Full text external link opens in a new window

385. Alexander R, Ravi A, Barclay H, et al. Guidance for the Treatment and Management of COVID-19 Among People with Intellectual Disabilities. J Policy Pract Intellect Disabil. 2020 Jun 10 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

386. Alexander R, Ravi A, Barclay H, et al. Guidance for the Treatment and Management of COVID-19 Among People with Intellectual Disabilities. J Policy Pract Intellect Disabil. 2020 Jun 10 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

387. Sultan S, Altayar O, Siddique SM, et al. AGA Institute rapid review of the GI and liver manifestations of COVID-19, meta-analysis of international data, and recommendations for the consultative management of patients with COVID-19. Gastroenterology. 2020 Jul;159(1):320-34.e27.Full text external link opens in a new window Abstract external link opens in a new window

388. European Academy of Neurology. Headache in COVID-19 pandemic. Apr 2020 [internet publication].Full text external link opens in a new window

389. Terpos E, Engelhardt M, Cook G, et al. Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN). Leukemia. 2020 Aug;34(8):2000-11.Full text external link opens in a new window Abstract external link opens in a new window

390. British Society for Haematology. UK Myeloma Forum guidance to support medical decision-making in the management of myeloma patients during the COVID-19 (Coronavirus) outbreak. Mar 2020 [internet publication].Full text external link opens in a new window

391. Medicines and Healthcare products Regulatory Agency guidance. Immunomodulatory drugs: temporary pregnancy prevention guidance during coronavirus (COVID-19). May 2020 [internet publication].Full text external link opens in a new window

392. Terpos E, Trougakos IP, Gavriatopoulou M, et al. Low neutralizing antibody responses against SARS-CoV-2 in elderly myeloma patients after the first BNT162b2 vaccine dose. Blood. 16 Apr 2021 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

393. Association of British Neurologists. ABN guidance on the use of disease-modifying therapies in multiple sclerosis in response to the COVID-19 pandemic. Nov 2020 [internet publication].Full text external link opens in a new window

394. National Multiple Sclerosis Society. MS treatment guidelines during coronavirus. 2020 [internet publication].Full text external link opens in a new window

395. Louapre C, Collongues N, Stankoff B, et al. Clinical characteristics and outcomes in patients with coronavirus disease 2019 and multiple sclerosis. JAMA Neurol. 2020 Jun 26;77(9):1-10.Full text external link opens in a new window Abstract external link opens in a new window

396. Salter A, Fox RJ, Newsome SD, et al. Outcomes and risk factors associated with SARS-CoV-2 infection in a North American registry of patients with multiple sclerosis. JAMA Neurol. 2021 Mar 19 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

397. Salter A, Fox RJ, Newsome SD, et al. Outcomes and risk factors associated with SARS-CoV-2 infection in a North American registry of patients with multiple sclerosis. JAMA Neurol. 2021 Mar 19 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

398. American Society for Hematology. COVID-19 and aggressive lymphoma: frequently asked questions. Feb 2021 [internet publication].Full text external link opens in a new window

399. Chieffo A, Stefanini GG, Price S, et al. EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic. Eur Heart J. 2020 May 14;41(19):1839-51.Full text external link opens in a new window Abstract external link opens in a new window

400. Rashid M, Timmis 3A, Kinnaird T, et al. Racial differences in management and outcomes of acute myocardial infarction during COVID-19 pandemic. Heart. 2021 May;107(9):734-40.Full text external link opens in a new window Abstract external link opens in a new window

401. Public Health England. Excess weight and COVID-19: insights from new evidence. July 2020 [internet publication].Full text external link opens in a new window

402. Hendren NS, de Lemos JA, Ayers C, et al. Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry. Circulation. 2021 Jan 12;143(2):135-44.Full text external link opens in a new window Abstract external link opens in a new window

403. Popkin BM, Du S, Green WD, et al. Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships. Obes Rev. 2020 Nov;21(11):e13128.Full text external link opens in a new window Abstract external link opens in a new window

404. Kompaniyets L, Goodman A, Belay B, et al. Body mass index and risk for COVID-19-related hospitalization, intensive care unit admission, invasive mechanical ventilation, and death - United States, March-December 2020. MMWR Morb Mortal Wkly Rep. 2021 Mar 12;70(10):355-61.Full text external link opens in a new window Abstract external link opens in a new window

405. Kompaniyets L, Goodman A, Belay B, et al. Body mass index and risk for COVID-19-related hospitalization, intensive care unit admission, invasive mechanical ventilation, and death - United States, March-December 2020. MMWR Morb Mortal Wkly Rep. 2021 Mar 12;70(10):355-61.Full text external link opens in a new window Abstract external link opens in a new window

406. Gao M, Piernas C, Astbury NM, et al. Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study. Lancet Diabetes Endocrinol. 28 Apr 2021 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

407. Maas MB, Kim M, Malkani RG, et al. Obstructive Sleep Apnea and Risk of COVID-19 Infection, Hospitalization and Respiratory Failure. Sleep Breath. 2020 Sep 29:1-3 [internet publication].Full text external link opens in a new window Abstract external link opens in a new window

408. Cariou B, Hadjadj S, Wargny M, et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020 Aug;63(8):1500-15.Full text external link opens in a new window Abstract external link opens in a new window

409. Miller MA, Cappuccio FP. A systematic review of COVID-19 and obstructive sleep apnoea. Sleep Med Rev. 2020 Sep 8;55:101382 [internet publication].Full text external link opens in a new window Abstract external link opens in a new window

410. European Rhinologic Society. Information for rhinologists on COVID-19. Apr 2020 [internet publication].Full text external link opens in a new window

411. Royal College of Ophthalmologists. Glaucoma Service Management Plans during COVID-19. March 2020 [internet publication].Full text external link opens in a new window

412. Gittoes NJ, Criseno S, Appelman-Dijkstra NM, et al. Endocrinology in the time of COVID-19: management of calcium disorders and osteoporosis. Eur J Endocrinol. 2020 Aug;183(2):G57-65.Full text external link opens in a new window Abstract external link opens in a new window

413. Yu EW, Tsourdi E, Clarke BL, et al. Osteoporosis Management in the Era of COVID-19. J Bone Miner Res. 2020 Jun;35(6):1009-13.Full text external link opens in a new window Abstract external link opens in a new window

414. Mikuls TR, Johnson SR, Fraenkel L, et al. American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 3. 2021 Feb;73(2):e1-e12.Full text external link opens in a new window Abstract external link opens in a new window

415. Wahezi DM, Lo MS, Rubinstein TB, et al. American College of Rheumatology Guidance for the Management of Pediatric Rheumatic Disease During the COVID-19 Pandemic: Version 1. Arthritis Rheumatol. 2020 Nov;72(11):1809-19.Full text external link opens in a new window Abstract external link opens in a new window

416. NHS England. Coronavirus specialty guides. Management of palliative care in hospital during the coronavirus pandemic. Apr 2020 [internet publication].Full text external link opens in a new window

417. Center to Advance Palliative Care. COVID-19 response training. Apr 2020 [internet publication].Full text external link opens in a new window

418. Department of Health and Social Care. Novel coronavirus (COVID-19) standard operating procedure: running a medicines re-use scheme in a care home or hospice setting. Apr 2020 [internet publication].Full text external link opens in a new window

419. Jones CM, Radhakrishna G, Aitken K, et al. Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position. Br J Cancer. 2020 Sep;123(5):709-13.Full text external link opens in a new window Abstract external link opens in a new window

420. Miocinovic S, Ostrem JL, Okun MS, et al. Recommendations for deep brain stimulation device management during a pandemic. J Parkinsons Dis. 2020 Jul 28;10(3):903-10.Full text external link opens in a new window Abstract external link opens in a new window

421. Zaorsky NG, Yu JB, McBride SM, et al. Prostate cancer radiotherapy recommendations in response to COVID-19. Adv Radiat Oncol. 2020 Apr 1;5(4):659-65.Full text external link opens in a new window Abstract external link opens in a new window

422. American Society for Hematology. COVID-19 and pulmonary embolism: frequently asked questions. Jan 2021 [internet publication].Full text external link opens in a new window

423. National Institute for Health and Care Excellence. COVID-19 rapid guideline: renal transplantation. Aug 2020 [internet publication].Full text external link opens in a new window

424. British Transplantation Society and Renal Association. Guidance on management of transplant recipients diagnosed with or suspected of having COVID-19. Jul 2020 [internet publication].Full text external link opens in a new window

425. The Transplantation Society. Guidance on coronavirus for transplant clinicians. Jun 2020 [internet publication].Full text external link opens in a new window

426. Kidney Advisory Group, NHS Blood and Transplant. Guidance for re-opening and expansion of kidney transplant programs and COVID-19. Jun 2020 [internet publication].Full text external link opens in a new window

427. Boyarsky BJ, Werbel WA, Avery RK, et al. Antibody response to 2-Dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients. JAMA. 5 May 2021 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

428. D'Silva KM, Jorge A, Cohen A, et al. COVID-19 outcomes in patients with systemic autoimmune rheumatic diseases compared to the general population: a US multicenter, comparative cohort study. Arthritis Rheumatol. 10 Dec 2020 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

429. Panamerican League of Associations for Rheumatology. Recommendations for patients on coronavirus. Apr 2020 [internet publication].Full text external link opens in a new window

430. British Society for Rheumatology. Corticosteroid guidance. Nov 2020 [internet publication].Full text external link opens in a new window

431. National Institute for Health and Care Excellence. COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders. Mar 2021 [internet publication].Full text external link opens in a new window

432. British Society for Rheumatology. Corticosteroid guidance. Nov 2020 [internet publication].Full text external link opens in a new window

433. Medicines and Healthcare Products Regulatory Agency. Central Alerting System. Ibuprofen and coronavirus (COVID-19). Apr 2020 [internet publication].Full text external link opens in a new window

434. National Institute for Health and Care Excellence. COVID-19 rapid evidence summary: long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19. May 2020 [internet publication].Full text external link opens in a new window

435. US Food and Drug Administration. FDA advises patients on use of non-steroidal anti-inflammatory drugs (NSAIDs) for COVID-19. Mar 2020 [internet publication].Full text external link opens in a new window

436. European Medicines Agency. EMA gives advice on the use of non-steroidal anti-inflammatories for COVID-19. Mar 2020 [internet publication].Full text external link opens in a new window

437. Haberman RH, Castillo R, Chan A, et al. COVID-19 in Patients With Inflammatory Arthritis: A Prospective Study on the Effects of Comorbidities and Disease-Modifying Antirheumatic Drugs on Clinical Outcomes. Arthritis Rheumatol. 2020 [internet publication].Full text external link opens in a new window Abstract external link opens in a new window

438. European League Against Rheumatism. EULAR guidance for patients COVID-19 outbreak. Apr 2020 [internet publication].Full text external link opens in a new window

439. Gianfrancesco MA, Leykina LA, Izadi Z, et al. Race/ethnicity association with COVID-19 outcomes in rheumatic disease: Data from the COVID-19 Global Rheumatology Alliance Physician Registry. Arthritis Rheumatol. Nov 2020 [internet publication].Full text external link opens in a new window Abstract external link opens in a new window

440. Arthritis and Musculoskeletal alliance. Principles for COVID-19 Vaccination in Musculoskeletal and Rheumatology for Clinicians. Apr 2021 [internet publication].Full text external link opens in a new window

441. Panepinto JA, Brandow A, Mucalo L, et al. Coronavirus Disease among Persons with Sickle Cell Disease, United States, March 20-May 21, 2020. Emerg Infect Dis. 2020 Oct;26(10):2473-6.Full text external link opens in a new window Abstract external link opens in a new window

442. Sickle Cell Disease Association of America. Sickle cell disease and COVID-19: provider advisory. May 2020 [internet publication].Full text external link opens in a new window

443. World Health Organization. Smoking and COVID-19: scientific brief. Jun 2020 [internet publication].Full text external link opens in a new window

444. Hopkinson NS, Rossi N, El-Sayed Moustafa J, et al. Current smoking and COVID-19 risk: results from a population symptom app in over 2.4 million people. Thorax. 2021 Jan 5 [Epub ahead of print].Abstract external link opens in a new window

445. Public Health England. COVID-19: advice for smokers and vapers. Mar 2021 [internet publication].Full text external link opens in a new window

446. Rashid M, Timmis 3A, Kinnaird T, et al. Racial differences in management and outcomes of acute myocardial infarction during COVID-19 pandemic. Heart. 2021 May;107(9):734-40.Full text external link opens in a new window Abstract external link opens in a new window

447. AHA/ASA Stroke Council Leadership. Temporary emergency guidance to US stroke centers during the coronavirus disease 2019 (COVID-19) pandemic: on behalf of the American Heart Association/American Stroke Association Stroke Council Leadership. Stroke. 2020 Jun;51(6):1910-12.Full text external link opens in a new window Abstract external link opens in a new window

448. Stauffer WM, Alpern JD, Walker PF. COVID-19 and Dexamethasone: A Potential Strategy to Avoid Steroid-Related Strongyloides Hyperinfection. JAMA. 2020 Jul 30;324(7):623-4.Full text external link opens in a new window

449. Wainwright JJ, Mikre M, Whitley P, et al. Analysis of Drug Test Results Before and After the US Declaration of a National Emergency Concerning the COVID-19 Outbreak. JAMA. 2020 Sep 18;324(16):1674-7.Full text external link opens in a new window Abstract external link opens in a new window

450. Pollard MS, Tucker JS, Green HD. Changes in Adult Alcohol Use and Consequences During the COVID-19 Pandemic in the US. JAMA Netw Open. 2020;3(9):e2022942.Full text external link opens in a new window Abstract external link opens in a new window

451. Ochalek TA, Cumpston KL, Wills BK, et al. Nonfatal Opioid Overdoses at an Urban Emergency Department During the COVID-19 Pandemic. JAMA. 2020 Sep 18;324(16):1673-74.Full text external link opens in a new window Abstract external link opens in a new window

452. Mason M, Arukumar P, Feinglass J, et al. The pandemic stay-at-home order and opioid-involved overdose fatalities. JAMA. 23 Apr 2021 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

453. Friedman J, Beletsky L, Schriger DL. Overdose-Related Cardiac Arrests Observed by Emergency Medical Services During the US COVID-19 Epidemic. JAMA Psychiatry. 2020 Dec 3 [Epub ahead of print].Full text external link opens in a new window Abstract external link opens in a new window

454. Centers for Disease Control and Prevention. Increase in Fatal Drug Overdoses Across the United States Driven by Synthetic Opioids Before and During the COVID-19 Pandemic. Dec 2020 [internet publication].Full text external link opens in a new window

455. Fernandez-Ruiz R, Masson M, Kim M, et al. Leveraging the United States Epicenter to Provide Insights on COVID-19 in Patients With Systemic Lupus Erythematosus. Arthritis Rheumatol. 2020 Dec;72(12):1971-80.Full text external link opens in a new window Abstract external link opens in a new window

456. American Society for Haematology. COVID-19 and thalassemia: frequently asked questions. Sep 2020 [internet publication].Full text external link opens in a new window

457. Farmakis D, Giakoumis A, Cannon L, et al. COVID-19 and thalassaemia: A position statement of the Thalassaemia International Federation. Eur J Haematol. 2020 Oct;105(4):378-86.Full text external link opens in a new window Abstract external link opens in a new window

458. American Society for Hematology. COVID-19 and thrombotic thrombocytopenic purpura: frequently asked questions. Nov 2020 [internet publication].Full text external link opens in a new window

459. ENT UK. COVID-19 Adult Tonsillitis & Quinsy Guidelines. Apr 2020 [internet publication].Full text external link opens in a new window

460. Centers for Disease Control and Prevention. Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States. Mar 2021 [internet publication].Full text external link opens in a new window

461. NHS England. COVID-19: Provision of tuberculosis services update. Feb 2021 [internet publication].Full text external link opens in a new window

462. World Health Organization. Tuberculosis and COVID-19. 2020 [Internet publication].Full text external link opens in a new window

463. World Health Organization. COVID-19 highlights urgent need to reboot global effort to end tuberculosis. Mar 2021 [internet publication].Full text external link opens in a new window

464. Sebastian S, Walker G, Kennedy NA, et al. Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study. Lancet Gastroenterol Hepatol. 2021 Apr;6(4):271-81.Full text external link opens in a new window Abstract external link opens in a new window

465. Alexander J, Moran GW, Gaya DR, et al. SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement. Lancet Gastroenterol Hepatol. 2021 Mar;6(3):218-24.Full text external link opens in a new window Abstract external link opens in a new window

466. International Uveitis Study Group. Evolving Consensus Experience of the IUSG-IOIS-FOIS with uveitis in the time of COVID-19 infection. April 2020 [internet publication].Full text external link opens in a new window

467. Hung JCH, Li KKW. Implications of COVID-19 for uveitis patients: perspectives from Hong Kong. Eye (Lond). 2020;34(7):1163-64.Full text external link opens in a new window Abstract external link opens in a new window

468. Mao R, Qiu Y, He JS, et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020 Jul;5(7):667-78.Full text external link opens in a new window Abstract external link opens in a new window

469. Pan L, Mu M, Yang P, et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol. 2020 May;115(5):766-73.Full text external link opens in a new window Abstract external link opens in a new window

470. Zheng S, Fan J, Yu F, et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ. 2020 Apr 21;369:m1443.Full text external link opens in a new window Abstract external link opens in a new window

471. British Society for Haematology. BSH advice on vitamin B12 replacement during the COVID-19 pandemic. May 2020 [internet publication].Full text external link opens in a new window

472. National Institute for Health and Care Excellence. COVID-19 rapid guideline: vitamin D. Dec 2020 [internet publication].Full text external link opens in a new window

References

Reference articles